AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 15 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $527,000 | -86.5% | 23,108 | -92.0% | 0.00% | -100.0% |
| Q2 2021 | $3,893,000 | -1.3% | 288,637 | -5.2% | 0.00% | -33.3% |
| Q1 2021 | $3,945,000 | -4.9% | 304,338 | +3.5% | 0.00% | 0.0% |
| Q4 2020 | $4,149,000 | -8.1% | 293,913 | -0.9% | 0.00% | -25.0% |
| Q3 2020 | $4,514,000 | +38.6% | 296,568 | +38.9% | 0.00% | +33.3% |
| Q2 2020 | $3,257,000 | +8947.2% | 213,575 | +8402.2% | 0.00% | – |
| Q1 2020 | $36,000 | -62.1% | 2,512 | -46.6% | 0.00% | – |
| Q4 2019 | $95,000 | -3.1% | 4,700 | -74.6% | 0.00% | – |
| Q3 2019 | $98,000 | -33.3% | 18,496 | -17.0% | 0.00% | – |
| Q2 2019 | $147,000 | +9.7% | 22,296 | +7.9% | 0.00% | – |
| Q1 2019 | $134,000 | -77.2% | 20,658 | -76.1% | 0.00% | -100.0% |
| Q4 2018 | $589,000 | -0.3% | 86,408 | -2.9% | 0.00% | – |
| Q3 2018 | $591,000 | -5.6% | 88,995 | -20.0% | 0.00% | – |
| Q2 2018 | $626,000 | -14.6% | 111,230 | -21.3% | 0.00% | -100.0% |
| Q1 2018 | $733,000 | +74.9% | 141,330 | +52.9% | 0.00% | – |
| Q4 2017 | $419,000 | -57.5% | 92,460 | -41.2% | 0.00% | -100.0% |
| Q3 2017 | $986,000 | +10.5% | 157,312 | +8.2% | 0.00% | 0.0% |
| Q2 2017 | $892,000 | -43.3% | 145,400 | -32.2% | 0.00% | -50.0% |
| Q1 2017 | $1,573,000 | +6739.1% | 214,400 | +2758.7% | 0.00% | – |
| Q4 2016 | $23,000 | 0.0% | 7,500 | 0.0% | 0.00% | – |
| Q3 2016 | $23,000 | +9.5% | 7,500 | 0.0% | 0.00% | – |
| Q2 2016 | $21,000 | -4.5% | 7,500 | 0.0% | 0.00% | – |
| Q1 2016 | $22,000 | +15.8% | 7,500 | 0.0% | 0.00% | – |
| Q4 2015 | $19,000 | -58.7% | 7,500 | -40.0% | 0.00% | – |
| Q4 2014 | $46,000 | +15.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2014 | $40,000 | – | 12,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |